While studies have shown that PRDM15 is overexpressed in B-cell lymphomas and colon adenocarcinoma and contributes to tumorigenesis and radioresistance [43, 46], it remains unknow whether PRDM15 is implicated in CCA. This evidence concerns the gene PRDM15 and B-cell non-Hodgkin lymphoma.